7241 - 7250 of 8137 Results
Title
Year
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients2014OPENTitle: Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 3Start Page: 1340End Page: 1349Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci71640Best OA location URL: http://www.jci.org/articles/view/71640/files/pdfCitation Count: 219
-
RESTRICTEDTitle: The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid FormationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 136Issue #: 10Start Page: 3859End Page: 3868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/ja411577tCitation Count: 232
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials2014OPENTitle: Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trialsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 127Issue #: 6Start Page: 861End Page: 879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-014-1256-4Best OA location URL: https://europepmc.org/articles/pmc4034750?pdf=renderCitation Count: 216
-
OPENTitle: The effect of deep brain stimulation randomized by site on balance in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 7Start Page: 949End Page: 953Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25831Best OA location URL: https://europepmc.org/articles/pmc4057940?pdf=renderCitation Count: 49
- Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease2014OPENTitle: Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 111Issue #: 7Start Page: 2626End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1318306111Best OA location URL: https://www.pnas.org/content/pnas/111/7/2626.full.pdfCitation Count: 349
-
OPENTitle: Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐MennonitesJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25818Best OA location URL: https://europepmc.org/articles/pmc4013240?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Inhibition of glucosylceramide synthase stimulates autophagy flux in neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 129Issue #: 5Start Page: 884End Page: 894Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.12672Citation Count: 33
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study2014OPENTitle: Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70293-xBest OA location URL: https://europepmc.org/articles/pmc4643396?pdf=renderCitation Count: 632
- Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury2014OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: https://europepmc.org/articles/pmc4201593?pdf=renderCitation Count: 66
-
OPENTitle: Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 2Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.5528Best OA location URL: https://europepmc.org/articles/pmc3940333?pdf=renderCitation Count: 224